Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riociguat in Adult Delta F508 Homozygous Cystic Fibrosis
NCT02170025Phase 2Terminated
- Sponsor
- Bayer
- Start
- Sep 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of riociguat in cystic fibrosis (CF), sponsored by Bayer. Started Sep 2014; status: terminated.
02
Drugs
riociguat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02170025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170025.